Subscribe Now to GaBI Journal 2020
Read the latest news and development in generics and biosimilars research.

Subscribe now to GaBI Journal.

The scope of GaBI Journal, as one of the umbrella projects of GaBI, is broad and of interest and relevance to professionals active in clinical practice, pharmaceutical science and policy. Materials published in GaBI Journal include high quality research reports, literature reviews and case studies, all of which are peer reviewed.

GaBI Journal publishes independent, high quality, authoritative and peer reviewed scientific articles concerning any aspects of the research into and development of cost-effective medicines, irrespective of their sources.

GaBI Journal publishes manuscripts in all aspects of generic and biosimilar medicines, including but not limited to the development of formulations, production, testing (including equivalence – in vivo and in vitro), model development, regulatory issues, supply chain management and pharmacoeconomics. Experts are highly motivated to share their knowledge and professional experiences through their contributing articles.
Type of subscription *
Corporate - 5 copies per issue.
Preferred payment method *
Title *
First name *
Your answer
Last Name *
Your answer
Email *
Your answer
Job title
Your answer
Organization name *
Your answer
Address *
Your answer
Postcode *
Your answer
City/Town *
Your answer
Country *
Your answer
Your answer
Your answer
VAT no. (applicable to European Union countries)
Your answer
Additional comments
Your answer
Contact information
Pro Pharma Communications International
Postbus 10001, BE-2400 Mol, Belgium
Tel: +32 14 724 215

V19L04AZ GJ Sub Web 2020
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy